Skip to main content
Premium Trial:

Request an Annual Quote

Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers

NEW YORK ─ Immunovia said on Monday that it has signed a global licensing agreement with South Korea-based JW BioScience that gives Immunovia the intellectual property rights for two biomarkers for the early detection of pancreatic cancer.

The Lund, Sweden-based diagnostic company said it had discovered the biomarkers independently of JW BioScience, but they are also part of JW BioScience's intellectual property portfolio. Immunovia said it has now secured intellectual property rights to the biomarkers, which are part of the diagnostic signature for its Immray PanCan-d blood test for the early detection of pancreatic cancer.

Financial and other terms of the licensing agreement were not disclosed.

"By entering into this agreement, Immunovia and JW BioScience will also evaluate possibilities for commercial collaboration to enable early detection of pancreatic cancer in the Korean market," Immunovia CEO Patrik Dahlen said in a statement.

In August, the firm announced it had received final approval to begin patient testing for its Immray PanCan-d blood test in the US through its laboratory in Marlborough, Massachusetts.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.